OPEN END TURBO LONG - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000MD5HFW7

Real-time Bid/Ask 11:26:40 20/06/2024 BST
1.25 EUR / 1.26 EUR +3.72% Intraday chart for OPEN END TURBO LONG - FRESENIUS MEDICAL CARE
Current month-19.87%
1 month-26.22%
Date Price Change
20/06/24 1.26 +4.13%
19/06/24 1.21 -3.97%
18/06/24 1.26 -3.82%
17/06/24 1.31 -10.27%
14/06/24 1.46 -0.68%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 10:39 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer Morgan Stanley
WKN MD5HFW
ISINDE000MD5HFW7
Date issued 23/06/2022
Strike 24
Maturity Unlimited
Parity 10 : 1
Emission price 2.3
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.65
Lowest since issue 0.36
Spread 0.01
Spread %0.79%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.26 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.24%
Consensus